Novartis files COX-II contender amid class safety concerns

October 22, 2003

Novartis has submitted its COX-II inhibitor Prexige to US and European regulators with data from 13,000 clinical trial patients to …

Supplementary prescribing gets go ahead

October 22, 2003

Thousands of trained pharmacists and nurses will be able to prescribe drugs for chronic diseases by late 2004, the Government …

Increase marketing RoI or cut back, analysts warn

October 22, 2003

Pharmaceutical companies must make their sales and marketing more cost-effective or cut back, according to a new report.Analysts Datamonitor warn …

OGS extends Actelion relationship as Zavesca approved

October 22, 2003

Oxford GlycoSciences has announced the EU approval of its first product, Zavesca, and an extension to its co-marketing agreement with …

Red tape could suffocate European clinical trials

October 22, 2003

New measures intended to improve the competitiveness of clinical trials in Europe could have the opposite effect, a leading research …

BMS schizophrenia drug wins US approval

October 22, 2003

New atypical antipsychotic Abilify has gained FDA approval for the treatment of schizophrenia and is tipped to eventually become a …

National service framework leaders appointed

October 22, 2003

Key appointments for the Children's National Service Framework and the Long-term Conditions National Service Framework have been announced.The external working …

Government presses on with MCA merger

October 22, 2003

The UK Government is to press ahead with the merger of the Medicines Control Agency and its medical devices counterpart …

Bayer parallel import case reopened

October 22, 2003

A landmark legal battle over parallel trade of Bayer's blood pressure treatment Adalat has been re-commenced in the European Court …

New Bextra warnings add to COX-II doubts

October 22, 2003

New warnings on the label of second-generation COX-II inhibitor Bextra have added to doubts about the safety of the drug …

Pharmacia man tipped to head Celltech

October 22, 2003

Pharmacia's Head of Research and Development, Goran Ando, is tipped to become Celltech's new Chief Executive when its current incumbent …

Pharma marketing’s changing skills set

October 21, 2003
Business Services, Sales and Marketing marketing, recruitment, skills

Sales and marketing are undergoing something of a revolution as the pharmaceutical industry reacts to a multitude of challenges. Waning …

New FDA head promises improvements for workforce

October 21, 2003

The new FDA Commissioner, Dr Mark McClellan, has pledged that improvements in the working lives of staff will be a …

WTO close to agreeing medicines supply deal

October 21, 2003

World Trade Organisation ministers say they are close to striking a deal aimed at improving the provision of medicines to …

Local people to control foundation hospitals

October 21, 2003

Local people are to play a major role in deciding how the new, more autonomous foundation hospitals are to be …

Latest content